Asia-Pacific Bioabsorbable Stents Market Research Report – Segmented By Material, Absorption, Application, End User & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029)

Updated On: June, 2024
ID: 2080
Pages: 145

Asia-Pacific Bioabsorbable Stents Market Size (2024 to 2029)

The bioabsorbable stents market size in the Asia-Pacific is advancing to achieve USD 2720 million by 2029 from USD 403 million in 2024, growing at a CAGR of 46.5% in the course of the forecast period.

The rise in the adoption rate of bioabsorbable stents, which can naturally heal the artery and restore the moment for treating PAD and CAD diseases, is fueling the growth of the Asia Pacific bioabsorbable stents market. Government and private organizations are taking initiatives to develop advanced bioabsorbable stents which are fully absorbed into the body and highly effective, this is contributing to the growth of the APAC bioabsorbable stents market. The increasing prevalence of peripheral artery and coronary artery diseases in the aging population is also boosting up the growth rate of the Asia Pacific bioabsorbable stents market. 

Increasing focus on initiatives by private and public organizations for escalating clinical trials of bioabsorbable stents is expected to create more growth opportunities for the APAC market over the forecast period. A rising account of the geriatric population and a continuously increasing patient base are anticipated to boost the demand for bioabsorbable stents and expand growth opportunities for the stakeholders in the APAC bioabsorbable stents market. Growing expenditure for healthcare and advancing economies of the countries like China, India, Japan, and others in the Asia Pacific are expected to create lucrative opportunities for the market players in the region during the forecast period. The continuously rising rate of diseases is leading to an increasing adoption rate of bioabsorbable stents owing to the benefits associated with them, providing a number of opportunities for the growth of the APAC bioabsorbable stents market. 

Availability of alternatives for bioabsorbable stents, such as laser ablation therapy, xenograft, and others, are limiting the growth rate of the bioabsorbable stents market and are posing a significant challenge for the key players in the APAC bioabsorbable stents market. 

This research report on the APAC bioabsorbable Stents Market has been segmented and sub-segmented into the following categories.

Asia-Pacific Bioabsorbable Stents Market - By Material:

  • Polymer Stents
  • Metallic Stents

Asia-Pacific Bioabsorbable Stents Market - By Absorption Rate:

  • Slow Absorption Rate Stents
  • High Absorption Rate Stents

Asia-Pacific Bioabsorbable Stents Market - By Application:

  • Coronary Artery Disease
  • Peripheral Artery Disease

Asia-Pacific Bioabsorbable Stents Market - By End User:

  • Hospitals
  • Cardiac Centers

Asia-Pacific Bioabsorbable Stents Market - By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Regionally, China market is dominating the Asia Pacific bioabsorbable stents market. It is supposed to contribute a significant share of revenues during the forecast period owing to the factors like presence of key players in the region, and expansion of the healthcare sector due to technological innovations and advancements, the increasing prevalence of PAD and CAD diseases, the influx of novel and innovative products into the market developed by various companies. India market segment is rapidly growing and is foreseen to continue the trend during the forecast period due to the rise in the economy of the country and the presence of a large patient base in the Asia-Pacific region.


Companies playing a prominent role in the Asia-Pacific bioabsorbable stents market include Elixir Medical Corporation, Arterius Limited, Amaranth Medical Inc, Abbott Laboratories, Arterial Remodeling Technologies S.A., Biotronik, Kyoto Medical Planning Co Ltd., Reva Medical Inc, Tepha.Inc, SMT and Xenogenics Corporation.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample